As of 2025-03-20, the Relative Valuation of Ose Immunotherapeutics SA (OSE.PA) is 29.58 EUR. This relative valuation is based on P/E multiples. With the latest stock price at 6.54 EUR, the upside of Ose Immunotherapeutics SA based on Relative Valuation is 352.3%.
The range of the Relative Valuation is 15.95 - 36.51 EUR.
| Range | Selected | |
| Trailing P/E multiples | 16.4x - 17.4x | 16.9x |
| Forward P/E multiples | 7.6x - 15.0x | 11.3x |
| Fair Price | 15.95 - 36.51 | 29.58 |
| Upside | 143.8% - 458.2% | 352.3% |
| Date | P/E |
| 2025-03-19 | 3.12 |
| 2025-03-18 | 3.14 |
| 2025-03-17 | 3.11 |
| 2025-03-14 | 3.03 |
| 2025-03-13 | 3.07 |
| 2025-03-12 | 3.18 |
| 2025-03-11 | 2.76 |
| 2025-03-10 | 2.83 |
| 2025-03-07 | 2.98 |
| 2025-03-06 | 2.99 |
| 2025-03-05 | 3.01 |
| 2025-03-04 | 2.98 |
| 2025-03-03 | 3.14 |
| 2025-02-28 | 3.18 |
| 2025-02-27 | 3.20 |
| 2025-02-26 | 3.16 |
| 2025-02-25 | 3.16 |
| 2025-02-24 | 3.30 |
| 2025-02-21 | 3.42 |
| 2025-02-20 | 3.29 |
| 2025-02-19 | 3.25 |
| 2025-02-18 | 3.38 |
| 2025-02-17 | 3.33 |
| 2025-02-14 | 3.33 |
| 2025-02-13 | 3.45 |
| 2025-02-12 | 3.35 |
| 2025-02-11 | 3.24 |
| 2025-02-10 | 2.99 |
| 2025-02-07 | 3.05 |
| 2025-02-06 | 3.12 |
| 2025-02-05 | 3.04 |
| 2025-02-04 | 3.05 |
| 2025-02-03 | 3.04 |
| 2025-01-31 | 3.25 |
| 2025-01-30 | 3.17 |
| 2025-01-29 | 3.10 |
| 2025-01-28 | 3.20 |
| 2025-01-27 | 3.06 |
| 2025-01-24 | 3.04 |
| 2025-01-23 | 3.06 |
| 2025-01-22 | 3.06 |
| 2025-01-21 | 3.13 |
| 2025-01-20 | 3.12 |
| 2025-01-17 | 3.19 |
| 2025-01-16 | 3.18 |
| 2025-01-15 | 3.19 |
| 2025-01-14 | 3.19 |
| 2025-01-13 | 3.20 |
| 2025-01-10 | 3.22 |
| 2025-01-09 | 3.26 |